( en | de | ru )

 

Disambiguation of "Vandesompele, Jo"

Author of the publication

copydeleteadd this publication to your clipboard
LNCipedia 5: towards a reference set of human long non-coding RNAs.

, , , , , , and . Nucleic Acids Res., 47 (Database-Issue): D135-D139 (2019)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Jo Baier

Changyeon Jo

Il Jo

Jó Ueyama

Sungho Jo

 

Other publications of authors with the same name

RTPrimerDB: the Real-Time PCR primer and probe database., , , and . Nucleic Acids Res., 31 (1): 122-123 (2003)CiLiQuant: Quantification of RNA Junction Reads Based on Their Circular or Linear Transcript Origin., , , , , , and . Frontiers Bioinform., (2022)Zipper plot: visualizing transcriptional activity of genomic regions., , , , , , , and . BMC Bioinform., 18 (1): 231:1-231:9 (2017)Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers., , , , , , , , , and 27 other author(s). Clin Cancer Res, 21 (8): 1904-1915 (April 2015)decodeRNA - predicting non-coding RNA functions using guilt-by-association., , , , , and . Database J. Biol. Databases Curation, (2017)Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers, , , , , , , , , and 27 other author(s). Clinical Cancer Research, (September 2014)Translating expression profiling into a clinically feasible test to predict neuroblastoma outcome., , , , , , , , and . Clin Cancer Res, 13 (5): 1459--1465 (March 2007)Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas., , , , , , , , , and 4 other author(s). Genome Biol, 9 (10): R150 (2008)Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature., , , , , , , , , and 10 other author(s). Clin Cancer Res, 16 (5): 1532--1541 (March 2010)High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma., , , , , , , , , and 8 other author(s). Clin Cancer Res, 17 (15): 5082--5092 (August 2011)